Paranoia and agitation associated with olanzapine treatment.
al Jeshi
A
A
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D008297:Male; D000077152:Olanzapine; D010259:Paranoid Disorders / Q000139:chemically induced*; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013315:Stress, Psychological / Q000139:chemically induced*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine